View of Design, Development and Characterisation of Eudragit Rl100-Based Besifloxacin Hydrochloride-Loaded Nanoparticle Incorporated Ion-Sensitive in Situ Ophthalmic Gel for the Treatment of Keratoconjunctivitis

Return to Article Details Design, Development and Characterisation of Eudragit Rl100-Based Besifloxacin Hydrochloride-Loaded Nanoparticle Incorporated Ion-Sensitive in Situ Ophthalmic Gel for the Treatment of Keratoconjunctivitis Download Download PDF